Natalizumab and progressive multifocal leucoencephalopathy.
about
Immunotoxicity of monoclonal antibodiesAnalysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitisPractical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodiesFunctional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disordersSafety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesPre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.Rapidly progressive cerebellar ataxia in West WalesFunctional knock down of VCAM1 in mice mediated by endoplasmatic reticulum retained intrabodiesDisease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.
P2860
Q24653374-1DFFA184-1C5E-48D3-BDD5-CEB49DC0F8ADQ27349006-7E771E73-4A76-4C35-A64D-4DDC215DA19DQ27690917-65B2319D-B202-47B9-BE90-42D8480256A8Q28740884-AA75E3FD-6DCD-4789-96C6-771BD5870352Q33895804-D35F77BD-9882-49F0-805E-71B7CBAC98DBQ34230150-6B4059C6-8019-4D09-8315-B59A4DB277D0Q35050193-EDA52993-E475-42AB-B143-9B8990CFEB27Q36213635-E00F477E-99E4-49FC-944B-57C1B848A4C5Q37206687-A74E6C75-30C7-442D-AB89-1ED6E09922CCQ37997089-79193AE2-7B90-4F51-8AFC-1E180A744DADQ45071794-41F396AF-7049-4605-89A4-7F996BE3924F
P2860
Natalizumab and progressive multifocal leucoencephalopathy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Natalizumab and progressive multifocal leucoencephalopathy.
@ast
Natalizumab and progressive multifocal leucoencephalopathy.
@en
type
label
Natalizumab and progressive multifocal leucoencephalopathy.
@ast
Natalizumab and progressive multifocal leucoencephalopathy.
@en
prefLabel
Natalizumab and progressive multifocal leucoencephalopathy.
@ast
Natalizumab and progressive multifocal leucoencephalopathy.
@en
P2860
P356
P1476
Natalizumab and progressive multifocal leucoencephalopathy.
@en
P2093
J R Berger
P2860
P304
P356
10.1136/ARD.2006.058404
P407
P478
65 Suppl 3
P577
2006-11-01T00:00:00Z